110536 ⎘
ssDNA viruses; Details; Parvoviridae; Dependovirus, e.g. adenoassociated viruses New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
ANTIBODY-EVADING VIRUS VECTORS
#602CLOSED-ENDED LINEAR DUPLEX DNA FOR NON-VIRAL GENE TRANSFER
#603AAV CAPSID PROTEINS FOR NUCLEIC ACID TRANSFER
#604ADENOVIRUSES AND METHODS FOR USING ADENOVIRUSES
#605ADENO-ASSOCIATED VIRUS HAVING A VARIANT CAPSID PROTEIN, AND USE THEREOF
#606Modified adeno-associated virus 5 capsids and uses thereof
#607NOVEL AAV8 MUTANT CAPSIDS AND COMPOSITIONS CONTAINING SAME
#608Adeno-Associated-Virus Rep Sequences, Vectors and Viruses
#609Compositions and methods for modulating transduction efficiency of adeno-associated viruses
#610Engineered untranslated regions (UTR) for AAV production
#611GENE THERAPY FOR THE TREATMENT OF GALACTOSEMIA
#612ADENO-ASSOCIATED VIRUS (AAV) CLADES, SEQUENCES, VECTORS CONTAINING SAME, AND USES THEREFOR
#613Methods and compositions for modifying assembly-activating protein (AAP)-dependence of viruses
#614AAV VP1U CHIMERAS
#615HUMAN ANTI-AAV2 CAPSID POLYCLONAL ANTIBODY EPITOPES
#616METHODS AND COMPOSITIONS FOR MODULATING CELLULAR AGING
#617METHOD OF DETECTING AND/OR IDENTIFYING ADENO-ASSOCIATED VIRUS (AAV) SEQUENCES AND ISOLATING NOVEL SEQUENCES IDENTIFIED THEREBY
#618Adeno-associated virus virions with variant capsid and methods of use thereof
#619rAAV with chemically modified capsid
#620METHODS AND COMPOSITIONS FOR DELIVERY OF AGENTS ACROSS THE BLOOD-BRAIN BARRIER
#621RECOMBINANT AAV1, AAV5, AND AAV6 CAPSID MUTANTS AND USES THEREOF
#622Methods of expressing a polynucleotide of interest in the cone photoreceptors of a subject comprising the subretinal delivery of a therapeutically effective amount of a recombinant AAV9-derived vector
#623MODIFIED ADENO-ASSOCIATED VIRAL CAPSID PROTEINS FOR OCULAR GENE THERAPY AND METHODS OF USE THEREOF
#624CAPSID-MODIFIED, RAAV3 VECTOR COMPOSITIONS AND METHODS OF USE IN GENE THERAPY OF HUMAN LIVER CANCER
#625MUTANT OF ADENO-ASSOCIATED VIRUS (AAV) CAPSID PROTEIN
#626Adeno-associated virus vector
#627AAV capsids identified by in vivo library selection
#628COMPOSITIONS AND METHODS FOR DELIVERY OF AAV
#629Variant adeno-associated viruses and methods of using
#630VIRAL VECTORS EXHIBITING IMPROVED GENE DELIVERY PROPERTIES
#631FURTHER IMPROVED AAV VECTORS PRODUCED IN INSECT CELLS
#632DIRECTED EVOLUTION
#633Adenovirus and uses thereof
#634AAV-COMPATIBLE LAMININ-LINKER POLYMERIZATION PROTEINS
#635AAV SEROTYPES FOR BRAIN SPECIFIC PAYLOAD DELIVERY
#636RAAV with chemically modified capsid
#637AAV vectors for retinal and CNS gene therapy
#638GENOME-MODIFIED RECOMBINANT ADENO-ASSOCIATED VIRUS VECTORS
#639PEPTIDES HAVING SPECIFICITY FOR THE LUNGS
#640GENE THERAPY VECTORS COMPRISING S/MAR SEQUENCES
#641RECOMBINANT AAVS HAVING USEFUL TRANSCYTOSIS PROPERTIES
#642ADENO-ASSOCIATED VIRUS VARIANT CAPSIDS AND METHODS OF USE THEREOF
#643ADENO-ASSOCIATED VIRUS (AAV) CLADES, SEQUENCES, VECTORS CONTAINING SAME, AND USES THEREFOR
#644TRANSDUCTION OF INNATE IMMUNOCOMPETENT CELLS USING AAV6
#645Compositions and methods for delivery of AAV
#646Adeno-associated virus variant capsids and methods of use thereof
#647COMPOSITIONS AND METHODS FOR TREATING DUCHENNE MUSCULAR DYSTROPHY
#648Rational polyploid adeno-associated virus vectors for the treatment of disease
#649ADENO-ASSOCIATED VIRUS VARIANTS AND METHODS OF USE THEREOF
#650Vectors with modified initiation codon for the translation of AAV-Rep78 useful for production of AAV
#651METHODS AND COMPOSITIONS FOR ENGINEERED ASSEMBLY ACTIVATING PROTEINS (EAAPS)
#652VIRAL VECTOR FOR THE TARGETED TRANSFER OF GENES IN THE BRAIN AND SPINAL CORD
#653Fusion Proteins Comprising a Cell Surface Marker Specific VHH
#654MODIFIED AAV CAPSIDS AND USES THEREOF
#655NOVEL ADENO-ASSOCIATED VIRUS (AAV) VECTORS, AAV VECTORS HAVING REDUCED CAPSID DEAMIDATION AND USES THEREFOR
#656Adeno-associated viral vectors for treatment of Niemann-Pick Disease type-C
#657METHODS AND MATERIALS FOR PRODUCING RECOMBINANT VIRUSES IN EUKARYOTIC MICROALGAE
#658Methods and compositions for dual glycan binding AAV vectors
#659Hybrid recombinant adeno-associated virus serotype between AAV9 and AAVrh74 with reduced liver tropism
#660MODIFIED VIRAL CAPSIDS
#661Adeno-associated virus vector variants for high efficiency genome editing and methods thereof
#662Restrictive inverted terminal repeats for viral vectors
#663Method of using adeno-associated virus with variant capsid
#664Adeno-associated virus variant capsids and methods of use thereof
#665Modified AAV capsid proteins and uses thereof
#666METHOD OF INCREASING THE FUNCTION OF AN AAV VECTOR
#667CAPSID-MODIFIED RAAV VECTORS AND METHODS OF USE
#668LIVER TROPIC RECOMBINANT AAV6 VECTORS THAT EVADE NEUTRALIZATION
#669Gene therapeutics for treating bone disorders
#670AAV6 VARIANTS
#671Ancestral virus sequences and uses thereof
#672Recombinant adeno-associated vectors for targeted treatment
#673Methods and compositions for antibody-evading virus vectors
#674AAV's and uses thereof
#675ADENO-ASSOCIATED VIRUS LIBRARY
#676METHODS OF REDOSING GENE THERAPY VECTORS
#677MODIFIED RAAV CAPSID PROTEIN FOR GENE THERAPY
#678Adeno-associated viral vectors for gene therapy
#679High efficiency library-identified AAV vectors
#680Methods and materials for NT-3 gene therapy
#681Variant AAV capsids for intravitreal delivery
#682Methods of viral neutralizing antibody epitope mapping
#683Adeno-associated virus virion for gene transfer to nervous system cells
#684Method of increasing the function of an AAV vector
#685Methods and compositions for delivery of viral vectors across the blood-brain barrier
#686Modified viral vectors and methods of making and using the same
#687Methods of predicting ancestral virus sequences and uses thereof
#688Gene therapies for lysosomal disorders
#689AAV vectors
#690Gene therapy for mucopolysaccharidosis IIIA
#691Compositions and methods for producing recombinant AAV
#692Gene therapies for lysosomal disorders
#693Adeno-associated virus variant capsids and use for inhibiting angiogenesis
#694Inducible AAV Rep genes
#695Gene therapies for lysosomal disorders
#696AAV capsid production in insect cells
#697Adeno-associated virus variant capsids and methods of use thereof
#698Life-cycle-defective adenovirus helper viruses, their production and use for producing rAAV
#699PRODUCTION OF ADENO-ASSOCIATED VIRUSES IN INSECT CELLS
#700Compositions and methods for transient delivery of nucleases
#701ADENO-ASSOCIATED VIRUS VIRIONS WITH VARIANT CAPSID AND METHODS OF USE THEREOF
#702Mutated adeno-associated viral capsid proteins for chemical coupling of ligands, nanoparticles or drugs via thioether binding and production method thereof
#703METHOD OF INCREASING THE FUNCTION OF AN AAV VECTOR
#704AAV vectors targeted to the central nervous system
#705MUTATED PARVOVIRUS STRUCTURAL PROTEINS AS VACCINES
#706Adeno-associated virus (AAV) with modified phospholipase domain
#707Synthetic combinatorial AAV3 capsid library
#708Adeno-associated virus compositions for targeted gene therapy
#709APHERESIS METHODS AND USES
#710ENHANCED MODIFIED VIRAL CAPSID PROTEINS
#711Adenoviruses and methods for using adenoviruses
#712ADENO-ASSOCIATED VIRUS (AAV) CLADES, SEQUENCES, VECTORS CONTAINING SAME, AND USES THEREFOR
#713Chimeric capsids
#714Mutant viral capsid libraries and related systems and methods
#715Tropism-Modified Recombinant Viral Particles and Uses Thereof for the Targeted Introduction of Genetic Material into Human Cells
#716Vectors with modified initiation codon for the translation of AAV-REP78 useful for production of AAV
#717Method of detecting and/or identifying adeno-associated virus (AAV) sequences and isolating novel sequences identified thereby
#718Methods of predicting ancestral virus sequences and uses thereof
#719ADENO-ASSOCIATED VIRUS VIRIONS WITH VARIANT CAPSIDS AND METHODS OF USE THEREOF
#720Rational polyploid adeno-associated virus vectors for the treatment of disease
#721Adeno-associated virus capsid variants and methods of use thereof
#722FULLY-HUMAN POST-TRANSLATIONALLY MODIFIED ANTIBODY THERAPEUTICS
#723Method of detecting and/or identifying adeno-associated virus (AAV) sequences and isolating novel sequences identified thereby
#724Selective recovery
#725Assembly activating protein (AAP) and its use for the manufacture of parvovirus particles essentially consisting of VP3
#726Method of detecting and/or identifying adeno-associated virus (AAV) sequences and isolating novel sequences identified thereby
#727Capsid
#728Gene therapies for lysosomal disorders
#729Adeno-associated virus (AAV) clade f vector and uses therefor
#730Cell culture methods involving HDAC inhibitors or rep proteins
#731Recombinant AAV variants and uses thereof
#732COMPOSITIONS AND METHODS FOR STUDYING THE TAT GENE
#733Recombinant AAV1, AAV5, and AAV6 capsid mutants and uses thereof
#734Modified AAV capsid proteins and uses thereof
#735Mutant of adeno-associated virus (AAV) capsid protein
#736Compositions and methods for identifying RNA binding polypeptide targets
#737NOVEL RECOMBINANT ADENO-ASSOCIATED VIRUS CAPSIDS WITH ENHANCED HUMAN SKELETAL MUSCLE TROPISM
#738Gene therapy for ocular disorders
#739RAAV with chemically modified capsid
#740Methods and compositions for gene transfer across the vasculature
#741AAV vectors targeted to the central nervous system
#742AAVrh.10 variants with host antibody escape capabilities and altered tissue targeting properties
#743Methods and compositions for modifying assembly-activating protein (AAP)-dependence of viruses
#744AAV vectors targeted to oligodendrocytes
#745AAV virions with decreased immunoreactivity and uses therefor
#746AAV capsid designs
#747Variant adeno-associated viruses and methods of using
#748Adeno-associated virus (AAV) serotype 8 sequences, vectors containing same, and uses therefor
#749Adeno-associated-virus Rep sequences, vectors and viruses
#750Selective recovery
#751High-transduction-efficiency rAAV vectors, compositions, and methods of use
#752GENE TRANSFER COMPOSITIONS, METHODS AND USES FOR TREATING NEURODEGENERATIVE DISEASES
#753Adeno-associated virus variant capsids and methods of use thereof
#754Synthetic combinatorial AAV capsid library for targeted gene therapy
#755Treatment of diseases by liver expression of an enzyme which has a deoxyribonuclease (DNase) activity
#756Method for delivering RNA to neurons to treat herpes infections
#757Adeno-associated virus virions with variant capsid
#758Method of increasing the function of an AAV vector
#759AAV vectors produced by insect cells comprising REP52 and REP78 coding sequences with differential codon biases
#760VIRAL NANOPARTICLES AND METHODS OF USE THEREOF
#761Restrictive inverted terminal repeats for viral vectors
#762MUTANT ADENO-ASSOCIATED VIRUS VIRIONS AND METHODS OF USE THEREOF
#763Vectors with modified initiation codon for the translation of AAV-Rep78 useful for production of AAV
#764Viral vector for the targeted transfer of genes in the brain and spinal cord
#765Selective recovery
#766Recombinant adeno-associated viral vectors
#767Adeno-associated virus polynucleotides, polypeptides and virions
#768CAPSID-MODIFIED RAAV VECTOR COMPOSITIONS AND METHODS THEREFOR
#769Ancestral virus sequences and uses thereof
#770Recombinant AAVS having useful transcytosis properties
#771AAV8 mutant capsids and compositions containing same
#772AAV HEPARIN MUTANTS THAT DISPLAY SIGNIFICANTLY IMPROVED EYE AND BRAIN TRANSDUCTION
#773Therapeutic for treatment of diseases including the central nervous system
#774Methods of predicting ancestral virus sequences and uses thereof
#775Adeno-associated virus (AAV) clades, sequences, vectors containing same, and uses therefor
#776Anti-angiogenic miRNA therapeutics for inhibiting corneal neovascularization
#777Methods and compositions for antibody-evading virus vectors
#778Closed-ended linear duplex DNA for non-viral gene transfer
#779Method of detecting and/or identifying adeno-associated virus (AAV) sequences and isolating novel sequences identified thereby
#780Adeno-associated virus (AAV) clades, sequences, vectors containing same, and uses therefor
#781Adeno-associated virus (AAV) serotype 8 sequences, vectors containing same, and uses therefor
#782Capsid-modified rAAV vector compositions and methods therefor
#783Adeno-associated virus (AAV) clades, sequences, vectors containing same, and uses therefor
#784AAV production in insect cells, methods and compositions therefor
#785Methods and compositions for dual glycan binding AAV vectors
#786Materials and methods for delivering nucleic acids to cochlear and vestibular cells
#787AAV's and uses thereof
#788AAV with unique capsid protein VP1 and methods of using for treatment
#789RECOMBINANT VIRUS PRODUCTION USING MAMMALIAN CELLS IN SUSPENSION
#790Prostate-targeting adeno-associated virus serotype vectors
#791Adeno-associated virus vector variants for high efficiency genome editing and methods thereof
#792Methods and materials for producing recombinant viruses in eukaryotic microalgae
#793AAV VIRIONS WITH DECREASED IMMUNOREACTIVITY AND USES THEREFOR
#794High efficiency library-identified AAV vectors
#795Vectors with modified initiation codon for the translation of AAV-Rep78 useful for production of AAV
#796AAV capsid proteins for nucleic acid transfer
#797Composition and methods for highly efficient gene transfer using AAV capsid variants
#798CAPSID-MODIFIED RAAV VECTOR COMPOSITIONS HAVING IMPROVED TRANSDUCTION EFFICIENCIES, AND METHODS OF USE
#799Modification of n-terminal region of capsid proteins for enhanced properties of adeno-associated viruses
#800Selective recovery
#801Capsid-modified, RAAV3 vector compositions and uses in gene therapy of human liver cancer
#802COMPOSITIONS AND METHODS FOR ACHIEVING HIGH LEVELS OF TRANSDUCTION IN HUMAN LIVER CELLS
#803Adeno-associated viruses engineered for selectable tropism
#804Recombinant adeno-associated virus vectors to target medullary thyroid carcinoma
#805Variant AAV and Compositions, Methods and Uses for Gene Transfer to Cells, Organs and Tissues
#806Compositions and methods for transient delivery of nucleases
#807Recombinant adeno-associated vectors for targeted treatment
#808Method of preparing recombinant adeno-associated virus and recombinant baculovirus
#809Promoters for expression of heterologous genes
#810Methods and compositions for treating genetic eye diseases
#811ADENO-ASSOCIATED VIRUS VECTOR
#812RECOMBINANT AAV VECTORS FOR GENE THERAPY OF HUMAN HEMATOPOIETIC DISORDERS
#813Modified AAV capsids and uses thereof
#814Capsid
#815AAV vectors with high transduction efficiency and uses thereof for gene therapy
#816Adeno-associated virus variants and methods of use thereof
#817Mutated structural protein of a parvovirus
#818Compositions and methods for intravitreal delivery of polynucleotides to retinal cones
#819Method of increasing the function of an AAV vector
#820rAAV vector compositions, methods for targeting vascular endothelial cells and use in treatment of type I diabetes
#821Compositions and methods for transient delivery of nucleases
#822Capsid modified rAAV vectors and methods of use
#823Method of detecting and/or identifying adeno-associated virus (AAV) sequences and isolating novel sequences identified thereby
#824Recombinant AAV variants and uses thereof
#825Methods and compositions for targeted gene transfer
#826Compositions and methods for the production of scAAV
#827Recombinant adeno-associated virus capsids resistant to pre-existing human neutralizing antibodies
#828AAV vectors targeted to the central nervous system
#829Genome-modified recombinant adeno-associated virus vectors
#830Further improved AAV vectors produced in insect cells
#831Recombinant adeno-associated virus capsids resistant to pre-existing human neutralizing antibodies
#832Adeno-associated virus (AAV) serotype 8 sequences, vectors containing same, and uses therefor
#833Method of detecting and/or identifying adeno-associated virus (AAV) sequences and isolating novel sequences identified thereby
#834Methods of predicting ancestral virus sequences and uses thereof
#835High-transduction-efficiency rAAV vectors, compositions, and methods of use
#836AAV Vectors Targeted to Oligodendrocytes
#837Method of detecting and/or identifying adeno-associated virus (AAV) sequences and isolating novel sequences identified thereby
#838Selective recovery
#839AAV VIRIONS WITH DECREASED IMMUNOREACTIVITY AND USES THEREFOR
#840Assembly activating protein (AAP) and its use for the manufacture of parvovirus particles essentially consisting of VP3
#841CpG reduced factor VIII variants, compositions and methods and uses for treatment of hemostasis disorders
#842Recombinant adeno-associated vectors for targeted treatment
#843Recombinant adeno-associated vectors for targeted treatment
#844Recombinant adeno-associated vectors for targeted treatment
#845Recombinant adeno-associated vectors for targeted treatment
#846Selective recovery
#847ADENO-ASSOCIATED VIRUS SEROTYPE I NUCLEIC ACID SEQUENCES, VECTORS AND HOST CELLS CONTAINING SAME
#848ADENO-ASSOCIATED VIRUS VECTOR VARIANTS FOR HIGH EFFICIENCY GENOME EDITING AND METHODS THEREOF
#849METHOD OF INCREASING THE FUNCTION OF AN AAV VECTOR
#850Mutant viral capsid libraries and related systems and methods
#851Attenuated parvovirus vaccine for muscovy duck parvovirus and goose parvovirus (derzsy's disease)
#852Adeno-associated virus (AAV) clades, sequences, vectors containing same, and uses therefor
#853Recombinant adeno-associated virus capsids with enhanced human skeletal muscle tropism
#854VECTORS WITH MODIFIED INITIATION CODON FOR THE TRANSLATION OF AAV-REP78 USEFUL FOR PRODUCTION OF AAV
#855Vectors with modified initiation codon for the translation of AAV-REP78 useful for production of AAV
#856Chimeric capsids
#857AAV vectors for retinal and CNS gene therapy
#858Adeno-associated virus (AAV) serotype 8 sequences, vectors containing same, and uses therefor
#859Recombinant adeno-associated vectors for targeted treatment
#860Methods of viral neutralizing antibody epitope mapping
#861Methods of predicting ancestral virus sequences and uses thereof
#862Enhanced AAV-mediated gene transfer for retinal therapies
#863Adeno-associated virus virions with variant capsid and methods of use thereof
#864Viral vector for the targeted transfer of genes in the brain and spinal cord
#865Adeno-associated virus (AAV) clades, sequences, vectors containing same, and uses therefor
#866METHODS AND COMPOSITIONS FOR GENE DELIVERY TO ON BIPOLAR CELLS
#867Adeno-associated virus virions with variant capsid and methods of use thereof
#868Adeno-associated virus virions with variant capsid and methods of use thereof
#869rAAV vectors and methods for transduction of photoreceptors and RPE cells
#870SYNTHETIC COMBINATORIAL AAV CAPSID LIBRARY FOR TARGETED GENE THERAPY
#871Mutant adeno-associated virus virions and methods of use thereof
#872CAPSID-MODIFIED, RAAV3 VECTOR COMPOSITIONS AND USES IN GENE THERAPY OF HUMAN LIVER CANCER
#873Directed evolution and in vivo panning of virus vectors
#874Adeno-associated virus with site-directed mutagenesis and site-directed modification and preparation method and application thereof
#875Adeno-associated vectors for enhanced transduction and reduced immunogenicity
#876ADENO-ASSOCIATED VIRUS "X" ONCOGENE
#877AAV's and uses thereof
#878Methods of predicting ancestral virus sequences and uses thereof
#879Adeno-associated virus (AAV) serotype 8 sequences, vectors containing same, and uses therefor
#880Neutralization-resistant CDV mutants and viral vectors
#881Adeno-associated virus virions with variant capsid and methods of use thereof
#882Peptides having specificity for the lungs
#883Mutated parvovirus structural proteins as vaccines
#884Restrictive inverted terminal repeats for viral vectors
#885Method of detecting and/or identifying adeno-associated virus (AAV) sequences and isolating novel sequences identified thereby
#886AAV vectors produced by insect cells comprising REP52 and REP78 coding sequences with differential codon biases
#887Adeno-associated virus variants and methods of use thereof
#888Methods and compositions for dual glycan binding AAV vectors
#889Adeno-associated-virus Rep sequences, vectors and viruses
#890AAV capsid proteins for nucleic acid transfer
#891Enhanced AAV-mediated gene transfer for retinal therapies
#892Recombinant adeno-associated vectors for targeted treatment
#893Adeno-associated virus (AAV) glades, sequences, vectors containing same, and uses therefor
#894AAV variant
#895Vectors with modified initiation codon for the translation of AAV-REP78 useful for production of AAV
#896Anti-HER2 vaccine based upon AAV derived multimeric structures
#897AAV vectors targeted to oligodendrocytes
#898Adeno-associated virus virions with variant capsid and methods of use thereof
#899Adeno-associated virus virions with variant capsid and methods of use thereof
#900Attenuated parvovirus vaccine for Muscovy duck parvovirus and goose parvovirus (Derzsys disease)